Valeriana Officinalis.

Valerenic acid in valerian and the flavonoids in passionflower both modulate GABA-A receptors, the nervous system's main calming channel, so pairing them raises overall GABAergic tone. This is why the two have long been formulated together to support winding down toward rest.

Melatonin signals the internal clock that night has arrived through its MT1 and MT2 receptors, while valerian works on a separate GABA pathway to quiet arousal, so the two support the normal onset of sleep from different angles. Because both are calming, stacking them can add up to stronger drowsiness, so the combined evening dose is worth watching.

L-theanine shifts brain activity toward calming alpha waves and nudges the balance of GABA and glutamate, which sits alongside valerian's GABA-A modulation to support a settled, relaxed state without heavy sedation. The two act on the same calming systems by different routes.

Apigenin, the calming flavonoid concentrated in chamomile, binds the benzodiazepine site of GABA-A receptors, the same receptor family valerenic acid modulates. The two converge on one relaxation pathway, the biochemistry behind the traditional chamomile and valerian pairing for easing into rest.

Valerenic acid acts as a positive modulator at the GABA-A receptor, and lemon balm constituents inhibit GABA transaminase, the enzyme that breaks GABA down. The two reach the same inhibitory pathway from different points, which is why they have been formulated together for centuries.

Chamomile's flavone apigenin binds the benzodiazepine site of the GABA-A receptor, while valerenic acid modulates a different subunit interface on the same complex. Two distinct sites on one receptor is a specific, non-redundant overlap.

Magnesium sits in the NMDA receptor channel as a voltage-dependent block and also acts as a positive modulator at GABA-A, damping excitatory tone from the other side of the balance valerian works on. The glycinate carrier supplies glycine, itself an inhibitory neurotransmitter.

Glycine is an inhibitory neurotransmitter at its own strychnine-sensitive receptor and lowers core body temperature, a normal part of settling into sleep. It adds a channel valerian does not act on, so the two stack rather than compete.

Honokiol and magnolol potentiate GABA-A chloride currents at a site distinct from the benzodiazepine pocket. Combined with valerenic acid the effect on inhibitory tone is additive, which is why the two appear together in evening formulas.

Kavalactones modulate GABA-A binding and block voltage-gated sodium and calcium channels, so combining kava with valerian produces additive central sedation. This is an interaction to disclose and dose down for, not a free gain.

Withanolides and the triethylene glycol fraction of ashwagandha show GABA-mimetic activity, and the herb moderates the evening cortisol curve. That addresses the arousal side of restlessness while valerian works on inhibitory receptor tone.

Tryptophan feeds serotonin synthesis and from there the nightly melatonin signal, which sets timing rather than inhibitory tone. Valerian shifts receptor tone, so the two act on different arms of normal sleep onset.

5-HTP bypasses the rate-limiting hydroxylation step and raises serotonin availability, feeding overnight melatonin production. It complements valerian's receptor-level action one step further along than tryptophan.

Montmorency cherry carries measurable melatonin and raises tryptophan availability, which supports the timing signal for sleep onset. Pairing it with valerian covers timing and inhibitory tone together.

Valerenic acid is a positive allosteric modulator, so it amplifies the response to GABA rather than opening the channel itself and needs agonist present to act. Supplemental GABA acts mostly at peripheral and enteric receptors, which keeps this pairing at the low end of confidence.

Jatamansi is a close botanical relative of valerian and carries similar sesquiterpene constituents with calming activity. The pair is long-standing practice in Ayurvedic evening formulas.

Humulus lupulus and valerian root are combined in more commercial sleep preparations than any other herb pair, and most of the clinical work on valerian for sleep quality has been done on fixed valerian-hops combinations rather than on valerian alone. That means the combination evidence is in some respects better developed than the single-ingredient evidence. The pairing is conventional, not incidental.

Lavender contributes the monoterpenes linalool and linalyl acetate, a volatile oil chemistry quite unlike valerian's sesquiterpenoid valerenic acids. Blends combine them for that non-overlap. Anyone taking a prescribed sedative should have the combination reviewed by their clinician, since calming effects add up.

Scutellaria supplies baicalin and baicalein, flavones with documented binding at the GABA-A benzodiazepine site in laboratory assays. Valerenic acid modulates the same receptor at a different subunit position. Two agents acting on one receptor family would be expected to act in the same direction, which is a caution as much as a rationale, and the pair has not been measured together in people.

Magnesium acts as a physiological antagonist at NMDA receptors and as a positive modulator at GABA-A, which is the settled pharmacology behind its place in evening formulas. Valerenic acid modulates GABA-A through the beta subunit. The two arrive at the same receptor system by different routes; combining them adds effect rather than introducing a new one.

Pyridoxal 5-phosphate is the obligatory cofactor for glutamate decarboxylase, the enzyme that converts glutamate to GABA. Without adequate B6 the body cannot make GABA at a normal rate, whatever is happening at the receptor. This is textbook cofactor biochemistry and does not need a trial to state; it is also upstream of, not the same as, what valerian does.

Taurine is a weak agonist at glycine receptors and at GABA-A, established from receptor pharmacology. Valerenic acid is a modulator rather than an agonist at GABA-A, so the two occupy different positions on the same receptor. The combined direction is additive and should be counted as such by anyone already using a calming agent.

Caffeine antagonises adenosine A1 and A2A receptors, which is the mechanism behind its arousal effect and the reason it opposes anything taken to wind down in the evening. Caffeine has a half-life of several hours in most adults, so an afternoon dose is still circulating at bedtime. Nothing about valerian removes that; the two point in opposite directions.

Rhodiola is used as a daytime activating adaptogen, and its rosavins and salidroside are studied for alertness rather than sedation. Placing it in the same product as an evening root works against the timing logic of both. The sensible arrangement is separation by time of day, not by dose.

Myo-inositol supplies the phosphatidylinositol pool used in signal transduction downstream of several neurotransmitter receptors. That places it at a different level of the same signalling system from a receptor modulator. The rationale is mechanistic and there is no combination study behind it.